Framework contracts to speed up the development of and access to next-generation therapeutics for infectious diseases

HaDEA has published the Prior Information Notice (PIN) HADEA/2026/OP/0015-PIN: Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures - Next Generation Therapeutics for Infectious Diseases 

This upcoming call for tenders aims at speeding up the development of promising next-generation therapeutics for infectious diseases by adopting a competitive development in phases under pre-commercial procurement (PCP). The scope of the call is expected to cover the development of innovative therapeutics to treat viral infections, acute respiratory distress syndrome (ARDS) or sepsis resulting from infections.

This action supports the policy priority to enhance the availability and accessibility of medical countermeasures and critical medicines, to support innovation and access regarding such products and to ultimately enhance preparedness for future health emergencies in synergy with Horizon Europe. It also implements the EU4Health Programme’s general objective of improving the availability, accessibility and affordability of medicinal products and medical devices and crisis-relevant products.

Indicative budget: € 244 000 000 

Interested parties are invited to consult the EU Funding and Tenders Portal for the future publication of the contract notice and tender documents in May 2026.  

Background 

EU4Health is the fourth and largest of the EU health programmes. The EU4Health programme goes beyond an ambitious response to the COVID-19 crisis to address the resilience of European healthcare systems. The programme provides funding to national authorities, health organisations and other bodies through grants and public procurement, contributing to a healthier Europe. 

HaDEA manages the vast majority of the total EU4Health budget and implements the programme by managing calls for proposals and tenders from 2021 to 2027.